Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Robert Steyer
Articles From This Author
MUTUAL FUNDS
Are Fund Managers Better Than Their Funds?
By Robert Steyer
Apr 20, 2009 4:51 PM EDT
STOCKS
Can Regional Brokers Keep Outperforming?
By Robert Steyer
Feb 16, 2009 10:49 AM EST
STOCKS
Wyeth Deal's Big, but Pfizer Still Needs a Blockbuster
By Robert Steyer
Jan 26, 2009 4:43 PM EST
STOCKS
Cosmetic Surgery Stocks Keep Stiff Upper Lip
By Robert Steyer
Oct 28, 2008 5:05 PM EDT
STOCKS
For Abbott, Diversity Remains Paramount
By Robert Steyer
Aug 21, 2008 1:06 PM EDT
STOCKS
Legal Questions Still Dogging Wyeth
By Robert Steyer
Jul 21, 2008 12:37 PM EDT
STOCKS
Baxter International Hiding in Plain Sight
By Robert Steyer
Jul 1, 2008 6:59 AM EDT
INVESTING
Generic-Drug Stocks Still Under the Weather
By Robert Steyer
Jun 5, 2008 1:40 PM EDT
STOCKS
Need Defense? Think Medical Supplies
By Robert Steyer
Apr 11, 2008 6:44 AM EDT
STOCKS
The Real Winners of Drug Experimentation
By Robert Steyer
Apr 3, 2008 6:59 AM EDT
INVESTING
A Safer Way to Play the Drug Sector
By Robert Steyer
Feb 26, 2008 6:16 AM EST
STOCKS
Schering-Plough's Adjusted Profits Top Estimates
By Robert Steyer
Feb 12, 2008 2:56 PM EST
STOCKS
Reasons to Believe in Schering-Plough
By Robert Steyer
Feb 11, 2008 2:05 PM EST
INVESTING
Big Pharma Moving More Work Offshore
By Robert Steyer
Jan 25, 2008 2:06 PM EST
OPINION
Are IPOs Poised for Another Banner Year?
By Robert Steyer
Jan 21, 2008 11:07 AM EST
INVESTING
Big Pharma Considers Kicking the OTC Habit
By Robert Steyer
Dec 18, 2007 6:14 AM EST
PERSONAL FINANCE
Your Guide to Collecting Argillite Carvings
By Robert Steyer
Dec 12, 2007 1:40 PM EST
STOCKS
No Easy Fix for Pfizer
By Robert Steyer
Nov 29, 2007 2:14 PM EST
STOCKS
Is Mylan Cheap Yet?
By Robert Steyer
Nov 28, 2007 3:14 PM EST
STOCKS
Cephalon Still a Stressor
By Robert Steyer
Nov 6, 2007 4:04 PM EST
STOCKS
After Exubera, Uncertainty Reigns
By Robert Steyer
Oct 22, 2007 4:01 PM EDT
PERSONAL FINANCE
Hot Art From the Arctic
By Robert Steyer
Oct 19, 2007 9:47 AM EDT
STOCKS
Can Good Health Last for Medical IPOs?
By Robert Steyer
Sep 11, 2007 2:20 PM EDT
STOCKS
Challenges Persist for Glaxo
By Robert Steyer
Aug 22, 2007 4:43 PM EDT
STOCKS
J&J's Risperdal Gets New Uses
By Robert Steyer
Aug 22, 2007 4:35 PM EDT
STOCKS
Pfizer Finds New CFO
By Robert Steyer
Aug 22, 2007 11:18 AM EDT
STOCKS
FDA Approves Novartis Osteoporosis Drug
By Robert Steyer
Aug 20, 2007 5:19 PM EDT
STOCKS
Glaxo Drug Gets Black Box
By Robert Steyer
Aug 14, 2007 5:38 PM EDT
STOCKS
Wyeth Whacked on Drug Setbacks
By Robert Steyer
Aug 10, 2007 1:49 PM EDT
STOCKS
One Giant Leap for MannKind
By Robert Steyer
Aug 9, 2007 5:48 PM EDT
STOCKS
FDA Reviewing AstraZeneca's Nexium, Prilosec
By Robert Steyer
Aug 9, 2007 2:21 PM EDT
STOCKS
Another Setback for Wyeth Drug
By Robert Steyer
Aug 8, 2007 4:27 PM EDT
STOCKS
Earnings Beat Boosts Barr
By Robert Steyer
Aug 8, 2007 10:35 AM EDT
STOCKS
Onyx Shines on Nexavar Sales
By Robert Steyer
Aug 7, 2007 6:27 PM EDT
STOCKS
Profits Slide at King Pharmaceuticals
By Robert Steyer
Aug 7, 2007 1:34 PM EDT
STOCKS
Pfizer's HIV Drug Gets FDA Nod
By Robert Steyer
Aug 6, 2007 4:00 PM EDT
STOCKS
Alkermes Tops Estimates
By Robert Steyer
Aug 3, 2007 11:43 AM EDT
STOCKS
Schering-Plough to Sell Stock
By Robert Steyer
Aug 2, 2007 3:16 PM EDT
STOCKS
Watson Pharma CEO to Retire
By Robert Steyer
Aug 2, 2007 10:41 AM EDT
STOCKS
Earnings Fall at Sanofi
By Robert Steyer
Aug 1, 2007 4:36 PM EDT
STOCKS
Teva Runs Past Estimates
By Robert Steyer
Aug 1, 2007 2:46 PM EDT
STOCKS
Cephalon Comes Up Short
By Robert Steyer
Aug 1, 2007 1:30 PM EDT
STOCKS
Good News for Tysabri
By Robert Steyer
Jul 31, 2007 6:54 PM EDT
STOCKS
Wyeth Again Defends Pristiq
By Robert Steyer
Jul 31, 2007 6:38 PM EDT
STOCKS
Experts: Keep Glaxo Drug on the Market
By Robert Steyer
Jul 31, 2007 3:44 PM EDT
STOCKS
Midwest to Mull Sale
By Robert Steyer
Jul 31, 2007 3:33 PM EDT
STOCKS
J&J Cutting Jobs
By Robert Steyer
Jul 31, 2007 2:37 PM EDT
INSURANCE
Time to Buy Drugmaker Stocks?
By Robert Steyer
Jul 31, 2007 6:27 AM EDT
STOCKS
FDA Questions Tysabri for Crohn's Disease
By Robert Steyer
Jul 27, 2007 2:06 PM EDT
STOCKS
Soggy Numbers Crush Sepracor
By Robert Steyer
Jul 27, 2007 1:17 PM EDT
